Clinical Resources Core
临床资源核心
基本信息
- 批准号:10721316
- 负责人:
- 金额:$ 61.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAddressAdoptedAmerican IndiansAreaArthritisAutoimmunityBasic ScienceCOVID-19 pandemicCOVID-19 testingCOVID-19 therapeuticsCOVID-19 vaccineCardiovascular DiseasesCenters of Research ExcellenceCertificationCherokee IndianChild HealthChildhoodChronicClinicalClinical DataClinical InformaticsClinical InvestigatorClinical ResearchClinical TrialsClinical Trials Data Monitoring CommitteesClinical Trials NetworkCollaborationsCommunity OutreachContract ServicesContractsDataData AnalysesDatabasesDegenerative polyarthritisDevelopmentDiabetes MellitusDiseaseDisease OutcomeDissemination and ImplementationEffectivenessEnsureFeasibility StudiesFundingGrowthHealthHuman ResourcesHuman Subject ResearchIndividualInformaticsInfrastructureInpatientsInstitutionInstitutional Review BoardsInvestigationInvestmentsK-Series Research Career ProgramsLearningLife ExpectancyMalignant NeoplasmsMediationMedicalMentorsMinority GroupsNational Center for Advancing Translational SciencesNative American Research Center for HealthObesityOklahomaOutcomeParticipantPatient RecruitmentsPatientsPhasePlayPopulationProcessProtocols documentationRADx Underserved PopulationsRegistriesReproducibilityResearchResearch ActivityResearch PersonnelResearch Project GrantsResourcesRoleRuralRural MinoritySamplingScientistSiteSystemTherapeutic InterventionTranslational ResearchTribesUnderrepresented MinorityUnited States Indian Health ServiceUnited States National Institutes of HealthVariantViralWest VirginiaWorkbiobankcareerclinical infrastructurecohortcommunity engagementcommunity organizationscoronavirus diseasedata warehousehuman subjectimplementation researchimprovedinformatics infrastructureinnovationmemberminority communitiesminority health disparitynew growthpopulation healthprogramsrecruitrepositoryresearch facilityresponserural health disparitiessample collectionsatisfactiontherapeutic vaccinetranslational scientisttribal communityvaccine hesitancy
项目摘要
Although some improvement has been made since the Oklahoma Shared Clinical and Translational Resources
(OSCTR) initiation, Oklahoma remains consistently in or near the bottom 10% of states for the overall health of
its population. Oklahoma’s residents disproportionately suffer from chronic health problems, such as obesity,
diabetes, cardiovascular disease, and arthritis/autoimmunity. Oklahomans have a life expectancy of 4 years
shorter than the average US citizen, while American Indians have a life expectancy of more than 7 years
shorter than other groups within the US. With high percentages of rural (34%) and tribal (16%) populations,
Oklahoma has unique challenges and opportunities to implement clinical and translational research (CTR)
projects and dissemination and implementation research to improve health and disease outcomes. The Clinical
Resources (ClinRes) Core of the OSCTR has built a centralized system to support human subjects research
focused on these issues. The Core provides clinical research facilities and staff to assist with participant
recruitment and regulatory approvals, a CAP-certified Biorepository that has allowed the OSCTR to adopt or
establish registries, repositories, and cohorts to assist investigators in obtaining and utilizing high-quality
samples to support their research efforts, and infrastructure for accessing de-identified patient data to support
clinical research projects. These efforts have allowed the Core to support the careers of multiple CTR
investigators, including researchers who are members of the under-represented minority communities in the
state. The ClinRes Core will continue to provide this invaluable access to sample collections while supporting
the establishment and growth of new repositories focusing on the health issues of greatest concern to our
populations, including cancer, diabetes, and arthritis. The ClinRes core will continue to work with the
Community Engagement and Outreach (CEO) Core to build on the strong relationships developed with smaller
community organizations across the state during the COVID-19 pandemic. Together, these collaborations
enhance the overall opportunities of our CTR investigators to expand clinical study and trial access to residents
throughout the state to help increase participant diversity and address our rural and minority health disparities.
The ClinRes Core will continue to provide junior investigators with essential assistance with institutional IRB
applications, protocols, data safety monitoring boards, and other regulatory requirements and will work with the
Administrative Core to make access to resources and information more accessible to investigators, clinicians,
clinical research staff, and participants through the Gateway to Oklahoma portal. With the CEO Tribal
Engagement Unit, we will assist investigators in working with the Indian Health Service and tribal IRBs,
ensuring the protection of both individual human subjects and tribal community populations. Finally, we will
continue developing and supporting resources to grow our clinical research informatics capacity to facilitate
local and national research efforts.
尽管自俄克拉荷马州共享临床和转化资源以来已经取得了一些进步
(OSCTR) 启动后,俄克拉荷马州的整体健康状况始终处于或接近垫底的 10%
俄克拉荷马州的居民不成比例地患有肥胖等慢性健康问题,
患有糖尿病、心血管疾病和关节炎/自身免疫性疾病的俄克拉荷马人的预期寿命为 4 年。
比美国公民的平均寿命短,而美洲印第安人的预期寿命超过 7 年
农村人口(34%)和部落人口(16%)比例较高,
俄克拉荷马州在实施临床和转化研究 (CTR) 方面面临着独特的挑战和机遇
旨在改善健康和疾病结果的项目以及传播和实施研究。
资源 (ClinRes) OSCTR 核心建立了一个集中系统来支持人类受试者研究
该核心专注于这些问题,提供临床研究设施和人员来协助参与者。
招募和监管批准,经过 CAP 认证的生物样本库,允许 OSCTR 采用或
建立登记处、存储库和队列,以协助研究人员获取和利用高质量的
支持他们的研究工作的样本,以及用于访问去识别的患者数据以支持的基础设施
这些努力使核心能够支持多个 CTR 的职业生涯。
调查人员,包括属于代表性不足的少数族裔社区成员的研究人员
ClinRes Core 将继续提供对样本集合的宝贵访问,同时提供支持。
建立和发展新的知识库,重点关注我们最关心的健康问题
ClinRes 核心将继续与癌症、糖尿病和关节炎等人群合作。
社区参与和外展 (CEO) 核心,以与较小规模的企业建立牢固的关系为基础
在 COVID-19 大流行期间,全州各地的社区组织共同开展这些合作。
增强我们的 CTR 研究人员扩大临床研究和试验覆盖居民的总体机会
在全州范围内帮助增加参与者的多样性并解决我们的农村和少数民族的健康差距。
ClinRes Core 将继续通过机构 IRB 为初级研究人员提供必要的帮助
应用程序、协议、数据安全监控委员会和其他监管要求,并将与
管理核心,使调查人员更容易获取资源和信息,
临床研究人员和参与者通过 Gateway to Oklahoma 门户网站与 CEO Tribal 进行交流。
参与部门,我们将协助调查人员与印第安卫生服务局和部落 IRB 合作,
确保保护个体人类受试者和部落社区人口。
继续开发和支持资源,以提高我们的临床研究信息学能力,以促进
地方和国家的研究工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Hal Scofield其他文献
Robert Hal Scofield的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Hal Scofield', 18)}}的其他基金
Autoimmunity in Post-Traumatic Stress Disorder
创伤后应激障碍中的自身免疫
- 批准号:
10427168 - 财政年份:2020
- 资助金额:
$ 61.68万 - 项目类别:
Autoimmunity in Post-Traumatic Stress Disorder
创伤后应激障碍中的自身免疫
- 批准号:
10704565 - 财政年份:2020
- 资助金额:
$ 61.68万 - 项目类别:
ShEEP Request for Peggy Sue by Bio-Techne
ShEEP 请求 Bio-Techne 提供 Peggy Sue
- 批准号:
9906453 - 财政年份:2019
- 资助金额:
$ 61.68万 - 项目类别:
Mitochondrial dysfunction, metabolic syndrome and oxidative damage in Sjogren's Syndrome
干燥综合征中的线粒体功能障碍、代谢综合征和氧化损伤
- 批准号:
9387723 - 财政年份:2017
- 资助金额:
$ 61.68万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
镰状细胞病的克隆造血和遗传变异
- 批准号:
10638404 - 财政年份:2023
- 资助金额:
$ 61.68万 - 项目类别:
Mechanisms underlying mustard gas-induced conjunctival injury and use of lipid mediators as medical countermeasures
芥子气引起的结膜损伤的机制以及脂质介质作为医疗对策的使用
- 批准号:
10882060 - 财政年份:2023
- 资助金额:
$ 61.68万 - 项目类别:
Feasibility of Using PET Imaging for Detection of Treatment-Induced Changes in Chronic Neuroinflammation Following TBI
使用 PET 成像检测 TBI 后治疗引起的慢性神经炎症变化的可行性
- 批准号:
10703823 - 财政年份:2023
- 资助金额:
$ 61.68万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 61.68万 - 项目类别:
Evaluating the impacts of sea level rise on migration and wellbeing in coastal communities
评估海平面上升对沿海社区移民和福祉的影响
- 批准号:
10723570 - 财政年份:2023
- 资助金额:
$ 61.68万 - 项目类别: